StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Not quite break even but close

<< Previous

Bullboard Posts

Next >>

Comment by TrippinAgain01on Nov 15, 2022 8:22am

73 Views

Post# 35099165

RE:RE:Not quite break even but close

At this rate, SZLS may gain traction in the market by 2058 lol, talk about moving at a snails pace. If SZ had any common sense they would get a large company on board to legitimize Aristotle, but we all know this product is more than likely to be fake. If it really is what they claim it is, why after 20 months does not a single company want to join with them? Notice how the Aristotle sales numbers are hidden again. Of coarse the paid pumpers will try to act like things are going in the right direction lol so funny...

User image